GSK and other drugmakers fending off litigation claiming that gastrointestinal drug Zantac or a generic caused cancer have won a supreme court ruling in Canada, after also chalking up wins in the US.

Shares in GSK fell around 9% this morning after ... of lawsuits claiming harm by gastrointestinal drug Zantac to proceed to trial. Judge Vivian Medinilla of Delaware Superior Court issued an ...

Pharmaceutical giant GSK has won a potentially expensive personal injury case in the US over its heartburn medicine Zantac. Angela Valadez, an 89-year-old woman living in the state of Illinois ...

Some Delaware Supreme Court justices signaled they may be skeptical of a bid by GSK Plc ... lawsuits to proceed to trial over claims that the heartburn drug Zantac is linked to cancer.

Following a series of settlements and court wins ... small GSK shareholder. But the Zantac debacle risks undoing all that good work. Barclays analyst Emily Field says: “If they go to trial ...

GSK - formerly GlaxoSmithKline - has won its latest trial over whether its most popular drug caused cancer on Monday, after a jury found it was not the root cause of an American woman's illness.